Dean LeMar Mann

Title: Dean LeMar Mann: Innovator in Vaccine Adjuvants

Introduction

Dean LeMar Mann is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on vaccine adjuvants. With a total of 2 patents, Mann's inventions aim to enhance the efficacy of vaccines and cancer treatments.

Latest Patents

Mann's latest patents include the "Human lymphocyte vaccine adjuvant" and the "Human lymphocyte medium adjuvant." Both inventions relate to adjuvants derived from human lymphocytes. These adjuvants can be used in combination with traditional vaccines or cancer immunotherapy to enhance the immune response of patients. The adjuvants are derived from the supernatant collected from cultured activated lymphocytes, showcasing Mann's innovative approach to improving immunotherapeutic outcomes.

Career Highlights

Throughout his career, Dean LeMar Mann has worked with various organizations, including Hasumi, LLC and the University System of Maryland. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Mann has collaborated with notable individuals in his field, including Kenichiro Hasumi and Kim Graulich Hankey. These partnerships have likely played a role in the development and success of his innovative projects.

Conclusion

Dean LeMar Mann is a distinguished inventor whose work on vaccine adjuvants has the potential to significantly impact immunotherapy and vaccine efficacy. His contributions to the field reflect a commitment to enhancing patient care through innovative solutions.